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Background: To investigate functional aspects of silent ureteral stones with special focus on obstruction and its
relationship to renal anatomy. The present study is the first investigation of renal excretory function in patients with
silent ureteral stones.
Methods: Patients with primarily asymptomatic ureteral stones underwent a mercapto-acetyltriglycine (MAG-3)
renal scintigraphy prior to treatment, in addition to anatomic evaluation of renal units and serum creatinine levels.
The primary outcome measure was the presence or absence of obstruction. Secondary outcome measures were
kidney anatomy, grade of hydronephrosis, location of stones, stone size, and serum creatinine levels.
Results: During a ten-year period, 14 patients (median age 52.6 years; range 37.3 to 80.7 years) were included in
the study. The relative frequency of primarily asymptomatic ureteral stones among all patients treated for ureteral
stones in the study period was 0.7%. Eleven renal units showed some degree of hydronephrosis while 3 kidneys
were not dilated. On the MAG-3 scan, 7 patients had an obstruction of the ureter, 5 had no obstruction, and 2 had
dysfunction of the kidney. A statistically significant correlation was established between the grade of obstruction
and stone size (p = 0.02).
Conclusions: At the time of presentation, only 64.3% of the patients revealed an obstruction in the stone-bearing
renal unit. The degree of hydronephrosis and renal function were very diverse in this subgroup of patients with
ureteral stones. The onset of ureterolithiasis and the chronological sequence of obstruction remain unclear in
patients who have never experienced symptoms due to their stones.
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Nephrolithiasis is a common disease with a lifetime in-
cidence of approximately 15%; prevalence and incidence
rates are on the increase throughout the world [1-3].
At initial presentation, urinary stones may be associated
with symptoms (pain, infection, hematuria), or remain
asymptomatic as well as undetectable on radiologic studies
of the urinary tract [4-6]. Asymptomatic stones are typically
found in the collecting system of the kidney. Primarily
asymptomatic (or silent) stones in the ureter have been in-
vestigated recently and constitute a very rare sub-category
of nephrolithiasis [7,8]. The reasons why ureteral stones
remain silent are not clear.* Correspondence: Florian.Wimpissinger@gmx.at
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article, unless otherwise stated.Mercaptoacetyltriglycine (MAG-3) renal scintigraphy
is an established method to assess renal function in the
obstructed kidney [9]. Its use to determine renal function
in ureterolithiasis has been described previously [10]. In the
present study we aimed to investigate functional aspects
with special focus on obstruction. Patients with silent
ureteral stones prospectively received MAG-3 scintigraphy
prior to treatment as well as underwent anatomic evalu-
ation of renal units and serum creatinine levels.Methods
Patients
During a nine-year period, patients with asymptomatic
(silent) ureteral stones were selected prospectively from all
nephrolithiasis patients reporting at a urologic stone center.
Inclusion criteria were ureteral stones diagnosed randomly,
that had caused no symptoms. Exclusion criteria wereentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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pain, colic, gross hematuria, or urinary tract infection. The
study protocol was approved by the ethics committee of
The City of Vienna (Wiener Krankenanstaltenverbund).
All patients signed informed consent according to the
study protocol.
Outcome measures
The primary outcome measure was the presence or absence
of obstruction on MAG-3 renal scintigraphy in patients with
silent ureteral stones. Secondary outcome measures were
the morphology of the kidney and the collecting system,
location of stones (proximal, mid, distal ureter), stone size,
and serum creatinine levels.
Statistical analysis
Spearman’s rank correlation coefficient was used to assess
relationships between the grade of obstruction and the
grade of hydronephrosis, serum creatinine levels, stone
size, and stone location [11].
Results
Between 2004 and 2013, 14 patients with silent ureteral
stones were included in the study. Among 2012 patients
treated for ureterolithiasis during the study period, the fre-
quency of silent ureteral stones was 0.7%. The median age
of the 14 patients was 52.6 years (range, 37.3 to 80.7 years).
Characteristics of patients and stones are summarized
in Table 1. The morphology of the renal collecting system,
MAG-3 renal scintigraphy, and laboratory parameters are
shown in Table 2.
Relationships between outcome parameters assessed with
Spearman’s rank correlation coefficient are given in Table 3.Table 1 Patients and stones















Reduction 2 (14.3%)A significant correlation was established between stone size
and the degree of obstruction (rho = 0.61, p = 0.02). No sta-
tistically significant correlations were observed between the
degree of obstruction on the MAG-3 scan and the degree of
hydronephrosis (p = 0.84), serum creatinine levels (p = 0.18),
and stone location (p = 0.79).
Discussion
Silent ureteral stones are an interesting phenomenon and
have been reported only in two publications thus far [7,8].
Before the first description of silent ureteral stones estab-
lished as a primary diagnosis, asymptomatic ureteral calculi
had been studied as residual fragments following the treat-
ment of (primarily symptomatic) ureteral stones [12,13].
The aim of the present study was to identify patients
with the primary diagnosis of silent ureteral stones, and
investigate excretory function and the morphology of the
affected renal units in order to determine why the stones
caused no symptoms. MAG-3 scans were used to study ex-
cretory function and the grade of obstruction prior to stone
treatment [9]. Interestingly, the population of 14 patients
with silent ureteral stones exhibited different types of ob-
struction, grades of hydronephrosis, stone sizes, and kidney
function. According to these findings, the absence of
symptoms related to a ureteral stone does not mean that
the respective renal units are not obstructed. Furthermore,
the absence of symptoms is not correlated with the grade
of hydronephrosis or kidney function.
The high variability of renal obstruction and impairment
of function in this subgroup of patients with silent ureteral
stones is well correlated with studies concerning primarily
symptomatic ureteral stones [14].
In contrast to silent ureteral stones, Kelleher et al. found
a clear correlation between stone size (>5 mm), the pres-
ence of obstruction, and impairment of renal function in
acute calculus obstruction [15]. In another study of acute
obstructive urinary calculi, Gandolpho et al. established a
significant association between renal impairment and stone
size (1.1 to 2.0 cm) in nearly 70% of patients [16].
Sfakianakis et al. found an acute obstruction in 56.5%
of patients presenting with renal colic on MAG-3 scans
in the emergency setting [10]. Thus, pain is obviously
not directly related with obstruction.
Irving et al. studied renal function on the basis of
MAG-3 scans in 54 patients with symptomatic ureteral
calculi measuring > 4 mm in size; the stones had been
treated conservatively [17]. Irving et al. found that 28% of
their patients had “silent loss of function” during follow-up,
as established on follow-up scans. In this respect, primarily
asymptomatic ureteral stones may be regarded as a form of
“chronic obstruction.”
Biancani et al. were the first to study physiologic changes
caused by chronic obstruction in an animal model in 1976
[18]. Acute obstruction of the ureter led to a rapid increase
Table 2 Renal morphology and function/obstruction
Renal morphology MAG-3 scan
Stone size Hydronephrosis Parenchyma sCr Function
Patient No. Sex Age (mm) (grade 1–4) (mg/dL) (stone side) Obstruction Comments
1 M 57,2 17 3 Normal 1,13 45% Minimal
2 M 40,9 15 3 Normal 1,00 38% No
3 M 43,5 10 2 Normal 1,15 41% Moderate
4 M 58,9 8 3 Normal 0,70 45% Minimal
5 M 40,2 7 3 Normal 1,10 47% No
6 M 80,7 10 no Normal 1,14 48% No
7 M 47,8 25 3 Reduced 1,00 27% Moderate
8 M 42,1 20 2 Normal 1,30 21% n.a. No excretory function
9 M 68,4 10 no Normal 1,00 61% Severe
10 M 54,4 5 no Normal 1,11 49% No
11 M 80,3 10 2 Normal 3,20 64% Moderate
12 M 37,3 15 3 Reduced 1,20 0% n.a. No excretory function
13 F 58,5 7 2 Normal 0,7 48% Minimal
14 F 50,7 25 2 Normal 0,64 33% Moderate
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the ureter. Subsequently intraluminal pressure declined,
whereas deformation of the urinary tract persisted. Pri-
marily silent ureteral stones are found in a very diverse
patient population. At the time of presentation, renal units
may be obstructed or not; hydronephrosis may be present
or not; and renal function may be impaired or not. In
patients with just two dysfunctional renal units at the
time of presentation, obstruction appears to diminish
to some degree in most cases.
Most recently, Marchini et al. were the second group of
scientists who studied primarily silent ureteral stones [8].
In a highly selected cohort of 506 patients with ureteralTable 3 Correlation of grade of obstruction with grade of
hydronephrosis, stone size, serum creatinine level, and
stone location (Spearman rank correlation coefficient)












P value 0.79calculi, silent stones were found in 5.3% (27 patients).
The study was focused on preservation of kidney function.
Patients were investigated with DMSA scans after treatment
of the stones. In nine of the 27 patients, DMSA scans were
performed before and after treatment. The authors found
impaired kidney function in patients with silent ureteral
stones; mean postoperative function on the DMSA scan
was 31%. DMSA scans and serum creatinine levels revealed
no difference in kidney function before and after treatment.
With regard to secondary signs of obstruction on ultra-
sound, IVU, or CT and actual obstruction on renal scintig-
raphy, German et al. showed that morphological changes
are not directly correlated with the degree of obstruction –
even in patients with renal colic [19]. Only 34% of patients
with anatomical signs of obstruction had complete ob-
struction on renal scintigraphy, whereas 24% of patients
with renal colic had partial obstruction and no anatom-
ical signs of obstruction on CT. These findings concur
with those obtained in the present study: presumably
chronic silent ureteral stones are associated with different
degrees of hydronephrosis, renal function, and degree of
obstruction on MAG-3 scans.
Eisner et al. found that stones located in the proximal
ureter were associated with a greater degree of ureteral
dilation compared to those located in the distal ureter
[20]. In the present study focused of silent ureteral stones,
the degree of hydronephrosis was also higher in proximal
ureteral stones (88% hydronephrosis in proximal stones
versus 60% in distal stones); however, this finding was not
statistically significant. The only parameter that correlated
with the grade of obstruction was stone size (p = 0.02).
This relationship was first reported by Kelleher et al. in
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been established as an important factor in the planning
and outcome of treatment [21,22].
In conclusion, silent ureteral stones are clinically relevant.
Silent obstruction may lead to irreversible renal func-
tion impairment [12].
Limitations
The major limitation of the present study is the relatively
small number of investigated patients. Ureteral stones with
no symptoms constitute a rare subgroup of the nephro-
lithiasis population – even in high-volume stone centers
[7]. Larger samples of patients will be needed to obtain
statistically significant results. On the other hand, patients
with silent ureteral stones might just be an entirely hetero-
geneous group with different outcomes, depending on the
degree and duration of obstruction.
Examination of kidney function and obstruction in
patients with silent ureteral stones represents a snapshot
of renal units at the time of presentation. As these patients
have never experienced subjective symptoms, the chrono-
logical history of stone passage or formation – and its
impact on excretory function of the kidney over time –
cannot be studied at the time of presentation.
Conclusion
The present study is the first investigation of functional
aspects of silent ureteral stones emphasizing on the
presence and grade of obstruction seen on MAG-3
renal scintigraphy. In conjunction with two previous studies
on this topic – one focusing on patient characteristics and
the other examining kidney function after stone treat-
ment – the natural history of silent ureteral stones may
be summed up in two distinct characteristics:
1) Asymptomatic onset of obstruction,
2) Chronic persistence of the stone in the ureter with
different degrees of obstruction, morphological
changes in the ureter and kidney, and deterioration
of renal function.
Silent onset of obstruction appears to be the only event
that distinguishes these patients from those with acute
symptomatic ureteral calculi. Treatment of silent ureteral
stones and evaluation of kidney function are mandatory in
all of these cases.
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